You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Innovative Continuous Sanitization of Fresh Produce Harvesting Equipment

    SBC: En Solucion Inc            Topic: FDA

    Recent foodborne illness outbreaks traced to contaminated field harvesting equipment have highlighted the need for incorporating improved sanitization practices at the time of harvest. Field- harvested specialty crops represent 50% of the top ten foods linked to major recalls and outbreaks over the past five years. Proper sanitization of outdoor harvest equipment is made complicated by operational ...

    SBIR Phase I 2023 Department of Health and Human ServicesFood and Drug Administration
  2. SBIR Phase I:Development of an ultra-low-cost distributed wind turbine

    SBC: WINDWARD ENGINEERING, L.C.            Topic: EN

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project aims to address the declining U.S. distributed wind turbine (DWT) market and support the transition to renewable energy sources. The DWT market has experienced a decline since 2012, mostly due to low reliability and high levelized cost of energy. However, the deployment of DWTs is crucial to m ...

    SBIR Phase I 2023 National Science Foundation
  3. SBIR Phase I: Antibody Therapy that Targets Neoantigens in Acute Myeloid Leukemia via the Antibody Dependent Cell-mediated Cytotoxicity Mechanism of Natural Killer Cells

    SBC: ENABLE LIFE SCIENCES LLC            Topic: PT

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project focuses on the unique combination of cancer-specific antibodies and adoptive Natural Killer (NK) immune cells needed to offer personalizable cancer therapies.This innovation represents a platform technology that can spawn multiple innovative cancer treatments, which could positively impact lif ...

    SBIR Phase I 2023 National Science Foundation
  4. SBIR Phase I:Artificial Intelligence (AI)-Enabled African Language Database

    SBC: ESM Global Productions, LLC            Topic: LC

    The broader/commercial impact of this Small Business Innovation Research (SBIR) Phase I project is creating a tonally proficient Artificial Intelligence (AI)-enabled translation database for African languages. There are no such product or service that can accurately translate African languages, as African languages have traditionally been under-resourced by Western corporations. By 2050, almost 25 ...

    SBIR Phase I 2023 National Science Foundation
  5. SBIR Phase I: Software-Defined Networking and Resource Virtualization in Low Earth Orbit (LEO) Satellite Constellations

    SBC: UNINET LLC            Topic: SP

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is the extension of state-of-the-art terrestrial 5G technologies to non-terrestrial satellite networks. Non-terrestrial networks (NTNs) are the ideal hosts for many commercial applications involving monitoring, reconnaissance, and remote sensing such as agricultural planting, remote factory op ...

    SBIR Phase I 2023 National Science Foundation
  6. Geostatistical Software for Non-Parametric Geostatistical Modeling of Uncertainty

    SBC: BIO-ANALYTICS, INC.            Topic: NLM

    7. Project Summary/Abstract A key component in any investigation of association and/or cause-effect relationships between the environment and health outcomes is the availability of accurate and precise models of exposure. Because the cost of collecting field data is often prohibitive, it is critical to incorporate any source of secondary information available to supplement sparse datasets. Seconda ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  7. A Potent D-peptide Inhibitor of TNFα for Treatment of Rheumatoid Arthritis

    SBC: D BioTherapeutics, LLC            Topic: NIAMS

    Rheumatoid arthritis (RA) is a chronic, debilitating inflammatory disease with high medical and societal costs afflicting more than 1.6 million Americans. Blockade of TNFα-driven inflammation with approved anti-TNFα biologics (such as Humira®, Remicade®, Simponi®, and Enbrel®) is an effective treatment for many patients suffering from RA. However, due at least in part to the immunogenicity o ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  8. Modular Virtual Reality Therapeutic for Opioid and Stimulant Use Disorders

    SBC: INNATEVR LLC            Topic: NIDA

    PROJECT SUMMARY Opioid and/or Stimulant Use Disorders (OUD/StUD) are chronic, recurring conditions that if left untreated, pose a significant and ongoing public health and safety threat, with costs associated with OUD alone in the US exceeding one trillion dollars annually. Virtual Reality Cue Exposure (VRCE) employs safe and controlled repeated exposure to a variety of substance use cues and envi ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  9. Development of a sample preparation protocol for 3D kidney ultrastructural analysis and immunolabeling by light microscopy

    SBC: panluminate Inc.            Topic: 400

    Abstract The success of cohort studies such as the NIDDK Kidney Precision Medicine Project (KPMP) with its massive amount of samples depends on the cost and time-efficient evaluation of kidney biopsies at multiple scales. Assessing the structure of kidney tissue at the nanoscale (~10 nm) and evaluating the 3-D distribution of protein biomarkers in that context is, however, currently severely limit ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  10. SBIR Phase I:Artificial Intelligence (AI) chatbot providing flare-up support for patients with endometriosis

    SBC: Amie Health Inc            Topic: DH

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is a novel chatbot that provides support to endometriosis patients. Endometriosis is a debilitating chronic pain disorder that impacts approximately one in ten women in the United States -resulting in significant loss of productivity, low quality of life, and greater than $80 billion annual ec ...

    SBIR Phase I 2023 National Science Foundation
US Flag An Official Website of the United States Government